Spin Off • Life Science

Veritas Genetics Exits Veritas Intercontinental

On January 1, 2018, invested in life science company Veritas Intercontinental from Veritas Genetics

Investment Context
  • This is transaction in the Life Science sector.
  • This is transaction in Spain.
Investment Fate
  • Veritas Intercontinental was sold to a consortium of financial buyers in 2020.
  • Veritas Intercontinental was sold to a strategic buyer in 2022.

Explore All 191 Spin Off Life Science Deals - Search the Database Free


Investment Summary

Date January 1, 2018
Target Veritas Intercontinental
Sector Life Science
Sellers(s) Veritas Genetics
Deal Type Spin Off

Target Company

Veritas Intercontinental

Madrid, Spain
Veritas Intercontinental is a provider of whole genome and exome sequencing based analyses and genetic services for maternal-fetal medicine through large hospitals, specialized clinics and medical distributors. Veritas Intercontinental was founded in 2018 and is based in Madrid, Spain.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Seller Profile 1

SELLER

Veritas Genetics

Danvers, Massachusetts, United States

Category Company
Founded 2014
Sector Life Science
DESCRIPTION

Veritas Genetics is a provider of consumer genetics and whole genome sequencing services. Veritas Genetics was established in 2014 and is based in Danvers, Massachusetts.


Deal Context for Seller #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Spin Off 1 of 1
Country: Spain 1 of 1
Year: 2018 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-03 Curoverse

Somerville, Massachusetts, United States

Curoverse, Inc. is a computing and bioinformatics company. Biomedical data analysis is transforming medicine. Curoverse, Inc. was established in 2010 and is based in Somerville, Massachusetts.

Buy -

Explore Related M&A Activity